Mar 22 |
Biophytis Presented its Phase 3 Protocol in the Treatment of Sarcopenia
|
Oct 30 |
Biophytis and Innovation Solutions Pharma Sign a Partnership Agreement to Accelerate Market Access for Sarconeos (BIO101) in Brazil
|
Oct 27 |
Biophytis receives notice of delisting from Nasdaq
|
Oct 27 |
Biophytis Receives Notice of Delisting From NASDAQ and Announces It Will Request a Hearing Before the NASDAQ Hearings Panel
|
Sep 28 |
Biophytis reports 1H results
|
Sep 27 |
Biophytis Releases Its Half-Yearly Accounts as of 30 June 2023 and Provides an Update on Its Operations
|
Sep 26 |
Biophytis and Skyepharma sign partnership agreement for production of Sarconeos
|
Sep 26 |
Biophytis (BPTS) Soars 73% on Partnership With Skyepharma
|
Sep 25 |
Gold Moves Lower; TransCode Therapeutics Shares Surge
|
Sep 25 |
Biophytis shares surge 73% following partnership deal with Skyepharma
|